Robitussin 12 Hour Cough Relief Suspension, Extended Release
NDC Package 0031-8755-15
Package Information
Robitussin 12 Hour Cough Relief (dextromethorphan polistirex) suspension is usestemporarily relievescough due to minor throat and bronchial irritation as may occur with the common cold or inhaled irritantsthe impulse to cough to help you get to sleep. This formulation utilizes a suspension, extended release delivery system. Marketed by Haleon Us Holdings Llc, this product is identified by NDC 0031-8755 and is authorized under FDA application ANDA091135.
Identification & Billing
- RxCUI: 1373045 - dextromethorphan polistirex 30 MG in 5 mL 12HR Extended Release Oral Suspension
- RxCUI: 1373045 - 12 HR dextromethorphan polistirex 6 MG/ML Extended Release Suspension
- RxCUI: 1373045 - dextromethorphan polistirex (dextromethorphan HBr 30 MG) per 5 ML 12 HR Extended Release Suspension
- RxCUI: 1373045 - dextromethorphan polistirex 6 MG/ML 12 HR Extended Release Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0031 - Haleon Us Holdings Llc
- 0031-8755 - Robitussin 12 Hour Cough Relief
- 0031-8755-15 - 1 BOTTLE in 1 CARTON / 148 mL in 1 BOTTLE
- 0031-8755 - Robitussin 12 Hour Cough Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0031-8755-15 identifies a specific commercial package of 1 bottle in 1 carton / 148 ml in 1 bottle of Robitussin 12 Hour Cough Relief, a human over the counter drug labeled by Haleon Us Holdings Llc. This product is billed per "ML" milliliter and contains an estimated amount of 148 billable units per package. This suspension, extended release is formulated for oral use and contains dextromethorphan hydrobromide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Haleon Us Holdings Llc on July 05, 2016. The current certification is valid through December 31, 2026.
How is this Haleon Us Holdings Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00031875515. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 148 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.